ClinicalTrials.gov
public full text
Public Domain
Autotaxin: a Potential Biomarker for Breast Cancer.
The goal of this clinical trial is to test the efficiency of Autotaxin (ATX) as a biomarker for breast cancer patients. The main questions it aims to answer are; * is ATX a reliable tumor marker for breast cancer patients in diagnosis * can ATX differentiate cancer patients from non-cancer ones
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Autotaxin (ATX) as a Marker for Breast Cancer#1085942
- 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer#1101704
- A Study of ZN-c5 in Participants With Breast Cancer#967128
- An Interactive Trustworthy AI Pathology Copilot to Improve Biomarker-Driven Prognostic Stratification and Therapeutic Response Prediction#287277
- Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition#1279787
Record · ID 1322352
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive